Record Abstract Submission for BOPA Annual Conference 2026
BOPA is thrilled to announce that we have received an incredible number of 235 abstracts for our annual conference 2026. The record number of abstract is testament to our continued growth and support to practice research in cancer pharmacy. BOPA is committed to support the cancer pharmacy workforce in embedding research and innovation within their practice to develop evidence to guide best practice, in one of our vision pillars.
Abstract marking is now underway and authors of accepted abstract can expect to be informed by Friday 14th August.